1.
Stability indicating Rp-UPLC method development and validation for the simultaneous estimation of fosnetupitant and palonosetron in bulk and injection dosage form. Braz. J. Pharm. Sci. [Internet]. 2022 Dec. 23 [cited 2024 Jul. 17];58. Available from: https://revistas.usp.br/bjps/article/view/205313